Evidence map›Paper›PMID 30257662›Full record

ArticleBMC complementary and alternative medicine2018

Antibacterial mechanism of chelerythrine isolated from root of Toddalia asiatica (Linn) Lam.

Nan He, Peiqing Wang, Pengyu Wang, Changyang Ma, Wenyi Kang

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nan He
Peiqing Wang
Pengyu WangInstitute of Chinese Materia Medica, Henan University, Kaifeng, 475004, Henan, China.
Changyang MaInstitute of Chinese Materia Medica, Henan University, Kaifeng, 475004, Henan, China. macaya1024@sina.com.
Wenyi KangInstitute of Chinese Materia Medica, Henan University, Kaifeng, 475004, Henan, China. kangweny@hotmail.com.ORCID http://orcid.org/0000-0002-1822-6249
Henan University · CN

Funding

Grant from the Ministry of Science and Technology of the People's Republic of China (2017YFC1601400)Henan Province University Science and Technology Innovation Team (16IRTSTHN019)National cooperation Project of Henan Province (2015GH12)
6 · The paper itself

Abstract

backgroundAntimicrobial resistance was one of serious worldwide problems confused many researchers. To solve this problem, we explored the antibacterial effect of chelerythrine, a natural compound from traditional Chinese medicine and studied its action.

methodsThe contents of chelerythrine from different fractions of Toddalia asiatica (Linn) Lam (T. asiatica) were determined. The anti-bacterial activities of chelerythrine were tested by disc diffusion method (K-B method). Scanning electron microscopy (SEM), alkaline phosphatase (AKP), bacterial extracellular protein leakage and SDS-PAGE analysis were also used to investigate the antibacterial mechanism of chelerythrine.

resultsAnalytic results of High Performance Liquid Chromatography showed that the content of chelerythrine (1.97 mg/g) in the ethyl acetate fraction was the highest, followed by those of methanol fraction and petroleum ether fraction. The in vitro anti-bacterial mechanisms of chelerythrine from T. asiatica were assessed. Chelerythrine showed strong antibacterial activities against Gram-positive bacteria, Staphylococcus aureus (SA), Methicillin-resistant S. aureus (MRSA), and extended spectrum β-lactamase S. aureus (ESBLs-SA). The minimum inhibitory concentrations (MICs) of chelerythrine on three bacteria were all 0.156 mg/mL. Furthermore, results suggested that the primary anti-bacterial mechanism of chelerythrine may be attributed to its destruction of the channels across the bacterial cell membranes, causing protein leakage to the outside of the cell, and to its inhibition on protein biosynthesis. Images of scanning electron microscope revealed severe morphological changes in chelerythrine-treated bacteria except control, damage of parts of the cell wall and cell membrane as well as the leakage of some substances.

conclusionsChelerythrine isolated from root of Toddalia asiatica (Linn) Lam possesses antibacterial activities through destruction of bacterial cell wall and cell membrance and inhibition of protein biosynthesis.

Indexed as

Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsBenzophenanthridinesCell WallExtracellular SpaceMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMicroscopy, ElectronPlant ExtractsPlant RootsRutaceaeAnti-Bacterial AgentsBacterial ProteinsBenzophenanthridineschelerythrinePlant ExtractsAntibacterial mechanismChelerythrineHPLCStaphylococcus aureusToddalia asiatica (Linn) Lam.

Identifiers

PMID30257662
PMCPMC6158911
OpenAlexW2894131129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.